1.Advanced research technology for discovery of new effective compounds from Chinese herbal medicine and their molecular targets

Wong, VKW, Law, BYK,     More...

Wong, VKW, Law, BYK, Yao, XJ, Chen, X, Xu, SW, Liu, L, Leung, ELH     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 111, Pages 546-555

收錄情况： WOS SCOPUS

WOS核心合集引用: 20  2023影響因子:  9.1  发表年影響因子:  4.480 

2.Calycosin suppresses expression of pro-inflammatory cytokines via the activation of p62/Nrf2-linked heme oxygenase 1 in rheumatoid arthritis synovial fibroblasts

Su, XH, Huang, QC, C     More...

Su, XH, Huang, QC, Chen, JY, Wang, MJ, Pan, HD, Wang, R, Zhou, H, Zhou, ZQ, Liu, J, Yang, F, Li, T, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 113, Pages 695-704

收錄情况： WOS SCOPUS

WOS核心合集引用: 73  2023影響因子:  9.1  发表年影響因子:  4.480 

3.Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review

Huang, ZY, Huang, QJ     More...

Huang, ZY, Huang, QJ, Ji, LY, Wang, Y, Qi, XX, Liu, L, Liu, ZQ, Lu, LL     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 114, Pages 1-12

收錄情况： WOS SCOPUS

WOS核心合集引用: 42  2023影響因子:  9.1  发表年影響因子:  4.480 

4.Hederagenin and alpha-hederin promote degradation of proteins in neurodegenerative diseases and improve motor deficits in MPTP-mice

Wu, AG, Zeng, W, Won     More...

Wu, AG, Zeng, W, Wong, VKW, Zhu, YZ, Lo, ACY, Liu, L, Law, BYK     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2017, Volume 115, Pages 25-44

收錄情况： WOS SCOPUS

WOS核心合集引用: 54  2023影響因子:  9.1  发表年影響因子:  4.897 

5.Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway

Li, X, Fan, XX, Jian     More...

Li, X, Fan, XX, Jiang, ZB, Loo, WTY, Yao, XJ, Leung, ELH, Chow, LWC, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2017, Volume 115, Pages 45-55

收錄情况： WOS SCOPUS

WOS核心合集引用: 71  2023影響因子:  9.1  发表年影響因子:  4.897 

6.Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-kappa B signaling

Huang, LF, Dong, Y,     More...

Huang, LF, Dong, Y, Wu, JL, Wang, PX, Zhou, H, Li, T, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2017, Volume 125, Pages 150-160

收錄情况： WOS SCOPUS

WOS核心合集引用: 17  2023影響因子:  9.1  发表年影響因子:  4.897 

7.Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function

Feng, SL, Yuan, ZW,     More...

Feng, SL, Yuan, ZW, Yao, XJ, Ma, WZ, Liu, L, Liu, ZQ, Xie, Y     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 110, Pages 193-204

收錄情况： WOS SCOPUS

WOS核心合集引用: 34  2023影響因子:  9.1  发表年影響因子:  4.480 

8.Stauntoside B inhibits macrophage activation by inhibiting NF-kappa B and ERK MAPK signalling

Liu, JX, Tang, JS, Z     More...

Liu, JX, Tang, JS, Zuo, YH, Yu, Y, Luo, P, Yao, XS, Dong, Y, Wang, PX, Liu, L, Zhou, H     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 111, Pages 303-315

收錄情况： WOS SCOPUS

WOS核心合集引用: 50  2023影響因子:  9.1  发表年影響因子:  4.480 

9.A rapid and sensitive assay based on particle analysis for cell degranulation detection in basophils and mast cells

Huang, LF, Pi, J, Wu     More...

Huang, LF, Pi, J, Wu, JL, Zhou, H, Cai, JY, Li, T, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 111, Pages 374-383

收錄情况： WOS SCOPUS

WOS核心合集引用: 31  2023影響因子:  9.1  发表年影響因子:  4.480 

10.Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function (vol 110, pg 193, 2016)

Feng, SL, Yuan, ZW,     More...

Feng, SL, Yuan, ZW, Yao, XJ, Ma, WZ, Liu, L, Liu, ZQ, Xie, Y     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2016, Volume 111, Pages 545-545

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2023影響因子:  9.1  发表年影響因子:  4.480 

11.Improvement of glucocorticoid-impaired thymus function by dihydromyricetin via up-regulation of PPAR gamma-associated fatty acid metabolism

Ting, L, Yan, FG, Me     More...

Ting, L, Yan, FG, Meng, XY, Wang, JR, Kam, RKT, Zeng, X, Liu, ZQ, Zhou, H, Yang, F, Ren, RT, Liao, KS, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2018, Volume 137, Pages 76-88

收錄情况： WOS SCOPUS

WOS核心合集引用: 10  2023影響因子:  9.1  发表年影響因子:  5.574 

12.Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies

Yuan, ZW, Li, YZ, Li     More...

Yuan, ZW, Li, YZ, Liu, ZQ, Feng, SL, Zhou, H, Liu, CX, Liu, L, Xie, Y     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2018, Volume 128, Pages 153-166

收錄情况： WOS SCOPUS

WOS核心合集引用: 42  2023影響因子:  9.1  发表年影響因子:  5.574 

13.Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling

Zhang, Yueyang, Zou,     More...

Zhang, Yueyang, Zou, Binhua, Tan, Yanhui, Su, Jianbing, Wang, Yiyuan, Xu, Jialan, Tao, Lei, Li, Xiaojuan, Zhou, Hua, Liu, Liang     Less

Pharmacological Research[1043-6618], Published 2019, Volume 142, Pages 140-150

收錄情况： WOS SCOPUS

WOS核心合集引用: 32  2023影響因子:  9.1  发表年影響因子:  5.893 

14.Identification of an IKK beta inhibitor for inhibition of inflammation in vivo and in vitro

Chen, Q, Liu, J, Zhu     More...

Chen, Q, Liu, J, Zhuang, YX, Bai, LP, Yuan, Q, Zheng, SL, Liao, KS, Khan, MA, Wu, QB, Luo, C, Liu, L, Wang, H, Li, T     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2019, Volume 149,

收錄情况： WOS SCOPUS

WOS核心合集引用: 15  2023影響因子:  9.1  发表年影響因子:  5.893 

15.SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells

Xu, SuWei, Law, Bett     More...

Xu, SuWei, Law, Betty Yuen Kwan, Qu, Steven Li Qun, Hamdoun, Sami, Zhang, Wei, Guo, JianRu, Mok, Simon Wing Fai, Zhang, David Wei, Liu, Liang, Wong, Vincent Kam Wai, Efferth, Thomas, Chen, Juan, Wu, AnGuo, Xia, Chenglai, Sugimoto, Yoshikazu     Less

Pharmacological Research[1043-6618], Published 2020, Volume 153,

收錄情况： WOS SCOPUS

WOS核心合集引用: 34  2023影響因子:  9.1  发表年影響因子:  7.658 

16.Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020

Zheng, Y, Xiong, C,     More...

Zheng, Y, Xiong, C, Liu, YQ, Qian, X, Tang, YJ, Liu, L, Leung, ELH, Wang, MF     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2020, Volume 157,

收錄情况： WOS SCOPUS

WOS核心合集引用: 47  2023影響因子:  9.1  发表年影響因子:  7.658 

17.ISO/TC 249 platform promotes the development of international standardization and trade for the Chinese medicines industry

Huang, YuFeng, He, F     More...

Huang, YuFeng, He, Fan, Xie, Ying, Liu, Liang, Zhou, Hua     Less

Pharmacological Research[1043-6618], Published 2020, Volume 160,

收錄情况： WOS SCOPUS

WOS核心合集引用: 12  2023影響因子:  9.1  发表年影響因子:  7.658 

18.Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients

Pan, HuDan, Yao, Xia     More...

Pan, HuDan, Yao, XiaoJun, Wang, WanYing, Liu, Liang, Lau, HungYan     Less

Pharmacological Research[1043-6618], Published 2020, Volume 159,

收錄情况： WOS SCOPUS

WOS核心合集引用: 16  2023影響因子:  9.1  发表年影響因子:  7.658 

19.Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway

Xie, YaJia, Gao, Wei     More...

Xie, YaJia, Gao, WeiNa, Wu, QiBiao, Yao, XiaoJun, Jiang, ZeBo, Wang, YuWei, Wang, WenJun, Hussain, Shahid, Liu, Liang, Leung, Elaine LaiHan, Fan, XingXing, Li, Wei     Less

Pharmacological Research[1043-6618], Published 2020, Volume 159,

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2023影響因子:  9.1  发表年影響因子:  7.658 

20.The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis

He, YuFei, Mai, ChuT     More...

He, YuFei, Mai, ChuTian, Pan, Hudan, Liu, Liang, Xie, Ying, Huang, Yadan, Luo, HaiBin     Less

Pharmacological Research[1043-6618], Published 2020, Volume 161,

收錄情况： WOS SCOPUS

WOS核心合集引用: 16  2023影響因子:  9.1  发表年影響因子:  7.658